Filter News
Area of Research
- (-) Neutron Science (10)
- (-) Nuclear Science and Technology (2)
- Advanced Manufacturing (2)
- Biology and Environment (16)
- Clean Energy (22)
- Climate and Environmental Systems (1)
- Computational Biology (1)
- Computational Engineering (3)
- Computer Science (4)
- Fusion Energy (1)
- Isotopes (2)
- Materials (12)
- Materials for Computing (3)
- Mathematics (1)
- National Security (15)
- Quantum information Science (2)
- Supercomputing (35)
News Topics
- (-) Biomedical (8)
- (-) Cybersecurity (1)
- (-) Summit (4)
- 3-D Printing/Advanced Manufacturing (5)
- Advanced Reactors (6)
- Artificial Intelligence (2)
- Big Data (1)
- Bioenergy (5)
- Biology (4)
- Biotechnology (1)
- Chemical Sciences (1)
- Climate Change (1)
- Composites (1)
- Computer Science (7)
- Coronavirus (5)
- Decarbonization (2)
- Energy Storage (4)
- Environment (4)
- Frontier (1)
- Fusion (3)
- High-Performance Computing (1)
- Isotopes (3)
- Materials (9)
- Materials Science (17)
- Microscopy (2)
- Molten Salt (3)
- Nanotechnology (7)
- National Security (1)
- Neutron Science (64)
- Nuclear Energy (18)
- Physics (8)
- Quantum Science (5)
- Security (1)
- Space Exploration (6)
- Sustainable Energy (3)
- Transformational Challenge Reactor (1)
- Transportation (3)
Media Contacts
![2018-P07635 BL-6 user - Univ of Guelph-6004R_sm[2].jpg 2018-P07635 BL-6 user - Univ of Guelph-6004R_sm[2].jpg](/sites/default/files/styles/list_page_thumbnail/public/2018-P07635%20BL-6%20user%20-%20Univ%20of%20Guelph-6004R_sm%5B2%5D.jpg?itok=DUdZNt_q)
A team of scientists, led by University of Guelph professor John Dutcher, are using neutrons at ORNL’s Spallation Neutron Source to unlock the secrets of natural nanoparticles that could be used to improve medicines.
![Radiochemical technicians David Denton and Karen Murphy use hot cell manipulators at Oak Ridge National Laboratory during the production of actinium-227. Radiochemical technicians David Denton and Karen Murphy use hot cell manipulators at Oak Ridge National Laboratory during the production of actinium-227.](/sites/default/files/styles/list_page_thumbnail/public/2016-P07827%5B1%5D.jpg?itok=yJbnFQLU)
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.